In the last trading session, 2,150,025 Hims & Hers Health, Inc. (NYSE:HIMS) shares changed hands as the company’s beta touched 0. With the company’s per share price at $11.2 changed hands at $0.1 or 0.01% during last session, the market valuation stood at $2.15 Billion. HIMS’s last price was a discount, traded about -126.79% off its 52-week high of $25.4. The share price had its 52-week low at $8.09, which suggests the last value was 27.77% up since then. When we look at Hims & Hers Health, Inc.’s average trading volume, we note the 10-day average is 1.68 Million shares, with the 3-month average coming to 1.48 Million.
Analysts gave the Hims & Hers Health, Inc. (HIMS) stock a consensus recommendation rating of Overweight, calculated at a mean rating of 2.2. If we narrow down to specifics, the data shows that none out of 4 analysts rate the stock as a Sell, with a further none assigning it an Overweight rating. Of the remaining, 2 recommended HIMS as a Hold, 2 felt it is a Buy and none rated the stock as Underweight. Hims & Hers Health, Inc.’s EPS for the current quarter is expected to be -$0.11.
Hims & Hers Health, Inc. (NYSE:HIMS) trade information
Instantly HIMS was in green as seen at the end of in last trading. With action 0.9%, the performance over the past five days has been red. The jump to weekly highs of $12.80 on Tuesday, Jun 15 added 12.5% to the stock’s daily price. The company’s shares are showing year-to-date downside of -0.23%, with the 5-day performance at -0.13% in the red. However, in the 30-day time frame, Hims & Hers Health, Inc. (NYSE:HIMS) is -0.13% down. Looking at the short shares, we see there were 14.04 Million shares sold at short interest cover period of 9.49 days.
The consensus price target for the stock as assigned by Wall Street analysts is $14.25, meaning bulls need an upside of 27.23% from its current market value. According to analyst projections, HIMS’s forecast low is $11 with $16 as the target high. To hit the forecast high, the stock’s price needs a +42.86% upsurge from its current level, while the stock would need to tank -1.79% for it to hit the projected low.
Hims & Hers Health, Inc. (HIMS) estimates and forecasts
Looking at the company’s year-on-year earnings, data shows that the past 5-year has an earnings growth rate of 0%. The 2021 estimates are for Hims & Hers Health, Inc. earnings to decrease by -365.7%, but the outlook for the next 5-year period is at 0% per year.
Hims & Hers Health, Inc. (NYSE:HIMS)’s Major holders
If we look at who the major shareholders are, we find that insiders hold 20.45% of Hims & Hers Health, Inc. shares while 58.14% of the shares are in the hands of institutional holders. The share float percentage for the stock currently stands at 73.09%. There are 101 institutions holding the Hims & Hers Health, Inc. stock share, with Thrive Capital Management, LLC the top institutional holder. As of Mar 30, 2021, the company held 8.34% of the shares, roughly 15.3 Million HIMS shares worth $202.47 Million.
Disruptive Technology Advisers, LLC holds the second largest percentage of outstanding shares, with 5.01% or 9.19 Million shares worth $121.54 Million as of Mar 30, 2021.
Among Mutual Funds, the top two as of Mar 30, 2021 were Vanguard Total Stock Market Index Fund and Vanguard Small-Cap Index Fund. With 2320400 shares estimated at $30.7 Million under it, the former controlled 1.27% of total outstanding shares. On the other hand, Vanguard Small-Cap Index Fund held about 1.08% of the shares, roughly 1.99 Million shares worth around $26.27 Million.